Screener
IMCV vs BBH
iShares Morningstar Mid-Cap Value ETF vs VanEck Biotech ETF
Key differences
Both IMCV and BBH are equity ETFs. IMCV charges 0.06% a year and BBH 0.35%. The main difference: IMCV costs 0.29% less per year.
- IMCV costs 0.29% less per year.
- Over the last three years, IMCV has delivered higher annualized returns.
- IMCV has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IMCV | BBH | |
|---|---|---|
| Annual cost (TER) | 0.06% | 0.35% |
| Fund size (AUM) | $1.0B | $367M |
| Since | 2004 | 2011 |
| Dividend yield | 1.95% | 0.51% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +25.1% | +21.9% |
| CAGR 3Y | +16.6% | +6.6% |
| CAGR 5Y | +9.1% | -0.2% |
| Sharpe 3Y | 0.90 | 0.25 |
| Volatility 1Y | 11.75% | 19.41% |
| Max drawdown | -46.33% | -39.86% |
Beyond the comparison: Beacon helps you build, track, and project a portfolio with the ETFs you pick.